Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
| Previous Close | 278.53 |
| Open | 270.89 |
| Bid | 283.90 x 0 |
| Ask | 284.00 x 0 |
| Day's Range | 278.16 - 286.00 |
| 52 Week Range | 253.48 - 325.00 |
| Volume | |
| Avg. Volume | 3,817,812 |
| Market Cap | 344.939B |
| Beta (5Y Monthly) | 0.08 |
| PE Ratio (TTM) | 30.40 |
| EPS (TTM) | 9.36 |
| Earnings Date | Apr 28, 2024 - May 13, 2024 |
| Forward Dividend & Yield | 8.80 (3.16%) |
| Ex-Dividend Date | Nov 22, 2023 |
| 1y Target Est | 394.79 |
Insider Monkey15 Countries with the Highest Life Expectancy in Asia
In this article, we will look at the 15 countries with the highest life expectancy in Asia. If you wish to skip our detailed analysis, you can go directly to 5 Countries with the Highest Life Expectancy in Asia. An Overview of Variations in Average Life Expectancy People across the world are living longer than […]
- Reuters
Chinese medical device firm Mindray plans $927 million deal to control APT Medical
BEIJING/HONG KONG (Reuters) -Chinese medical device company Shenzhen Mindray Bio-Medical Electronics said it planned a 6.65 billion yuan ($927 million) deal to gain control of APT Medical to expand in cardiovascular disease-related businesses. A wholly owned unit of Mindray will buy a 21.12% stake in APT Medical from current shareholders, including funds linked to venture investment firm Qiming Venture, for 6.65 billion yuan, Mindray said on Sunday. The Mindray unit will become the controlling shareholder of APT Medical after the transaction, according to a Mindray filing to the Shenzhen stock exchange.
South China Morning PostLuxury Hong Kong mansion on The Peak sells at 35% discount for US$107 million to company linked to Mindray founder
A mainland Chinese buyer snapped up an ultra-luxury house at The Peak in Hong Kong at a 35 per cent discount, reflecting the still lukewarm atmosphere in the city's luxury property market. The mansion, 25-26 A&B Lugard Road, sold for HK$838 million (US$107 million), or HK$71,703 per square foot, according to Godfrey Cheng, deputy senior director of the investment CEO office at Savills Hong Kong, the sole agent for the property. The sale is linked to Shenzhen entrepreneur Xu Hang, co-founder and
